US 7087591
21-substituted progesterone derivatives as new antiprogestational agents
granted A61PA61P15/00A61P15/04
Quick answer
US patent 7087591 (21-substituted progesterone derivatives as new antiprogestational agents) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P15/00, A61P15/04, A61P15/08, A61P5/24